Merck & Co., Inc.
XETRA: 6MK.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert Davis
- Employees
- 73,000
- Headquarters
- Rahway, United States
- IPO year
- 2007
- Market cap
- €235.0B
- Website
- https://www.merck.com
Loading 6MK…
Loading profile data…Frequently asked questions about 6MK
What does Merck & Co., Inc. (6MK.DE) do?
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such...
Where does 6MK.DE trade?
Merck & Co., Inc. (6MK.DE) trades on the Deutsche Börse.
What sector is 6MK.DE in?
Merck & Co., Inc. (6MK.DE) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Merck & Co., Inc.?
Robert Davis is the chief executive officer of Merck & Co., Inc. (6MK.DE).
Where is Merck & Co., Inc. headquartered?
Merck & Co., Inc. is headquartered in United States.
Does 6MK.DE pay a dividend?
Yes — Merck & Co., Inc. (6MK.DE) paid a trailing twelve-month dividend of EUR 2.82 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6MK.DE go public?
Merck & Co., Inc. (6MK.DE) completed its initial public offering in 2007.